tiletamine hydrochloride has been researched along with Hodgkin Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aldinucci, D; Borghese, C; Carbone, A; Casagrande, N; Celegato, M; Colombatti, A; Umezawa, K | 1 |
| Higashihara, M; Horie, R; Ishii, Y; Nakashima, M; Togano, T; Umezawa, K; Watanabe, M; Watanabe, T | 1 |
| Dewan, MZ; Higashihara, M; Honda, M; Horie, R; Kadin, ME; Sata, T; Shoda, M; Taira, M; Umezawa, K; Watanabe, M; Watanabe, T; Yamamoto, N | 1 |
3 other study(ies) available for tiletamine hydrochloride and Hodgkin Disease
| Article | Year |
|---|---|
The NF-κB inhibitor DHMEQ decreases survival factors, overcomes the protective activity of microenvironment and synergizes with chemotherapy agents in classical Hodgkin lymphoma.
Topics: Antineoplastic Agents; Benzamides; CD40 Antigens; Cell Line, Tumor; Chemokine CCL17; Chemokine CCL5; Cyclohexanones; Down-Regulation; Drug Synergism; Hodgkin Disease; Humans; Interferon Regulatory Factors; Interleukin-6; Ki-1 Antigen; NF-kappa B; Reactive Oxygen Species; Tumor Microenvironment | 2014 |
The side population, as a precursor of Hodgkin and Reed-Sternberg cells and a target for nuclear factor-κB inhibitors in Hodgkin's lymphoma.
Topics: Antibiotics, Antineoplastic; Apoptosis; Benzamides; Cell Line, Tumor; Cell Survival; Cyclohexanones; Doxorubicin; Drug Resistance; Flow Cytometry; Giant Cells; Hodgkin Disease; Humans; Immunohistochemistry; Ki-1 Antigen; Leukocytes, Mononuclear; Microscopy, Fluorescence; Neoplastic Stem Cells; NF-kappa B; Reed-Sternberg Cells | 2010 |
IkappaBalpha independent induction of NF-kappaB and its inhibition by DHMEQ in Hodgkin/Reed-Sternberg cells.
Topics: Animals; Apoptosis; Benzamides; Caspases; Cell Line; Cyclohexanones; Daunorubicin; Enzyme Activation; Etoposide; Hodgkin Disease; Humans; I-kappa B Kinase; I-kappa B Proteins; Leukocytes, Mononuclear; Mice; Mutation; Neoplasm Transplantation; NF-kappa B; NF-KappaB Inhibitor alpha; Reed-Sternberg Cells; Topoisomerase Inhibitors; Transplantation, Heterologous; Tumor Cells, Cultured | 2007 |